Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

35.61
Delayed Data
As of May 27
 +0.71 / +2.03%
Today’s Change
16.64
Today|||52-Week Range
51.99
-0.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues1.0K39.0K17.0K4.0K
 
 
 
 
 
Depreciation And Amortization280.0K117.0K128.0K138.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses39.2M38.9M43.0M50.1M
 
 
 
 
 
Other Operating Expenses0.000.002.5M0.00
 
 
Research And Development18.4M18.7M20.5M22.8M
 
 
 
 
 
Total Operating Expenses39.5M39.0M45.6M50.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.5M-39.0M-45.6M-50.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.4M-38.9M-45.5M-49.8M
 
 
 
 
 
Income Taxes0.000.00-330.0K0.00
 
 
Net Income-39.4M-38.9M-45.8M-49.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS100.3M100.8M101.2M111.3M
 
 
 
 
 
Shares To Calculate EPS Diluted100.3M100.8M101.2M111.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39-$0.39-$0.45-$0.45
 
 
 
 
 
EPS Diluted-$0.39-$0.39-$0.45-$0.45